Literature DB >> 24798135

Local control of perivascular malignant liver lesions using percutaneous irreversible electroporation: initial experiences.

Achim Eller1, Axel Schmid, Joachim Schmidt, Matthias May, Michael Brand, Marc Saake, Michael Uder, Michael Lell.   

Abstract

PURPOSE: This study was designed to assess efficacy and safety in the treatment of perivascular malignant liver lesions using percutaneous, computed tomography (CT)-guided irreversible electroporation (IRE).
METHODS: Fourteen patients (mean age 58 ± 11 years) with 18 malignant liver lesions were consecutively enrolled in this study. IRE was performed in patients not eligible for surgery and lesions abutting large vessels or bile ducts. Follow-up exams were performed using multislice-CT (MS-CT) or MRI.
RESULTS: Medium lesion diameter was 20 ± 5 mm. Ten of 14 (71 %) were successfully treated with no local recurrence to date (mean follow-up 388 ± 160 days). One case left initial tumor control unclear and additional RFA was performed 4 weeks after IRE. Complications occurred in 4 of 14 (29 %) cases. In one case, intervention was terminated and abdominal bleeding required laparotomy. In two cases, a postinterventional hematothorax required intervention. In another case, abdominal bleeding could be managed conservatively. No complications related to the bile ducts occurred.
CONCLUSIONS: Percutaneous IRE seems to be effective in perivascular lesions but is associated with a higher complication rate compared with thermoablative techniques.

Entities:  

Mesh:

Year:  2014        PMID: 24798135     DOI: 10.1007/s00270-014-0898-x

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  10 in total

Review 1.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

2.  Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis.

Authors:  Pankaj Gupta; Muniraju Maralakunte; Sathya Sagar; Praveen Kumar-M; Harish Bhujade; Sreedhara B Chaluvashetty; Naveen Kalra
Journal:  Eur Radiol       Date:  2021-02-27       Impact factor: 5.315

3.  Risk of local failure after ultrasound guided irreversible electroporation of malignant liver tumors.

Authors:  Robert M Eisele; Sascha S Chopra; Matthias Glanemann; Bernhard Gebauer
Journal:  Interv Med Appl Sci       Date:  2014-12-22

Review 4.  Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.

Authors:  Aydin Eresen; Jia Yang; Alessandro Scotti; Kejia Cai; Vahid Yaghmai; Zhuoli Zhang
Journal:  Ann Transl Med       Date:  2021-07

5.  Multi-Tissue Analysis on the Impact of Electroporation on Electrical and Thermal Properties.

Authors:  Natalie Beitel-White; Melvin F Lorenzo; Yajun Zhao; Rebecca M Brock; Sheryl Coutermarsh-Ott; Irving C Allen; Navid Manuchehrabadi; Rafael V Davalos
Journal:  IEEE Trans Biomed Eng       Date:  2021-02-18       Impact factor: 4.538

Review 6.  Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives.

Authors:  Asha Zimmerman; David Grand; Kevin P Charpentier
Journal:  J Hepatocell Carcinoma       Date:  2017-03-13

7.  Impact of needle positioning on ablation success of irreversible electroporation: a unicentric retrospective analysis.

Authors:  René Michael Mathy; Parham Tinoush; Ricardo Daniel da Florencia; Alexander Braun; Omid Ghamarnejad; Boris Radeleff; Hans-Ulrich Kauczor; De-Hua Chang
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

8.  Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery-IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable.

Authors:  Lea Hitpass; Martina Distelmaier; Ulf P Neumann; Wenzel Schöning; Peter Isfort; Sebastian Keil; Christiane K Kuhl; Philipp Bruners; Alexandra Barabasch
Journal:  Cardiovasc Intervent Radiol       Date:  2021-11-10       Impact factor: 2.740

Review 9.  Recent progress in pulsed electric field ablation for liver cancer.

Authors:  Zhen-Guo Liu; Xin-Hua Chen; Zu-Jiang Yu; Jun Lv; Zhi-Gang Ren
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

Review 10.  Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.

Authors:  Nana Zhang; Zhuoqun Li; Xuan Han; Ziyu Zhu; Zhujun Li; Yan Zhao; Zhijun Liu; Yi Lv
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.